trending Market Intelligence /marketintelligence/en/news-insights/trending/jv8j2twes3tastt80s4a4q2 content esgSubNav
In This List

Edge Therapeutics gets Nasdaq noncompliance notice

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Edge Therapeutics gets Nasdaq noncompliance notice

Edge Therapeutics Inc. received a notice of noncompliance from Nasdaq for failing to meet the stock exchange's minimum $1 bid price listing standard.

The exchange granted Edge Therapeutics 180 calendar days, or until March 4, 2019, to regain compliance with the rule.

The Berkeley Heights, N.J.-based biotechnology said the notice has no immediate effect on its common stock which trades under the EDGE symbol on the Nasdaq Global Select Market.